You can watch CytRx and buy or sell other stocks, options, ETFs, and crypto commission-free!
CytRx Corporation Common Stock, also called CytRx, is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. Read More The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.
Los Angeles, California
52 Week High
52 Week Low